-+ 0.00%
-+ 0.00%
-+ 0.00%

iRadimed Sees Q4 GAAP EPS $0.53-$0.57 vs $0.58 Est

Benzinga·10/30/2026 12:32:31
Listen to the news
iRadimed (NASDAQ:IRMD) is looking for Q4 GAAP EPS of $0.53-$0.57 vs $0.58 analyst estimate..